ERBB2 and breast carcinoma: More recently, we showed that MCF-10A cells overexpressing ERBB2 and ERBB2-positive breast cancer cells stabilizes HIF-1α levels and that HIF-1α is required for ERBB2 oncogenesis in vivo and anoikis resistance in vitro [21].